carbon monoxide has been researched along with Cardiometabolic Syndrome in 6 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Exhaled carbon monoxide (eCO) and fractional exhaled nitric oxide (FeNO) could reflect underlying inflammatory and oxidative stresses, which play important roles in pathogenetic pathways of metabolic syndrome (MetS)." | 7.83 | Associations of Exhaled Carbon Monoxide and Fractional Exhaled Nitric Oxide with Metabolic Syndrome: A Cohort Study. ( Chen, W; Guo, Y; He, J; Lu, W; Ma, J; Yuan, J; Zhang, R, 2016) |
| "Endogenous carbon monoxide (CO) at physiological concentrations is cytoprotective, whereas excess levels reflect underlying oxidative stress, inflammation, and vascular pathology and portend adverse clinical sequelae." | 7.76 | Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community. ( Cheng, S; Keaney, JF; Lyass, A; Massaro, JM; O'Connor, GT; Vasan, RS, 2010) |
| "Carbon monoxide (CO) has been recognized as a risk factor for adverse cardiovascular outcomes." | 5.35 | Exposure to environmental carbon monoxide may have a greater negative effect on cardiac autonomic function in people with metabolic syndrome. ( Cho, SI; Min, JY; Min, KB; Paek, D, 2009) |
| "Exhaled carbon monoxide (eCO) and fractional exhaled nitric oxide (FeNO) could reflect underlying inflammatory and oxidative stresses, which play important roles in pathogenetic pathways of metabolic syndrome (MetS)." | 3.83 | Associations of Exhaled Carbon Monoxide and Fractional Exhaled Nitric Oxide with Metabolic Syndrome: A Cohort Study. ( Chen, W; Guo, Y; He, J; Lu, W; Ma, J; Yuan, J; Zhang, R, 2016) |
| "Endogenous carbon monoxide (CO) at physiological concentrations is cytoprotective, whereas excess levels reflect underlying oxidative stress, inflammation, and vascular pathology and portend adverse clinical sequelae." | 3.76 | Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community. ( Cheng, S; Keaney, JF; Lyass, A; Massaro, JM; O'Connor, GT; Vasan, RS, 2010) |
| "Carbon monoxide (CO) has been recognized as a risk factor for adverse cardiovascular outcomes." | 1.35 | Exposure to environmental carbon monoxide may have a greater negative effect on cardiac autonomic function in people with metabolic syndrome. ( Cho, SI; Min, JY; Min, KB; Paek, D, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ponciano-Rodriguez, G | 1 |
| Paez-Martinez, N | 1 |
| Villa-Romero, A | 1 |
| Gutierrez-Grobe, Y | 1 |
| Mendez-Sanchez, N | 1 |
| Guo, Y | 1 |
| Ma, J | 1 |
| Lu, W | 1 |
| He, J | 1 |
| Zhang, R | 1 |
| Yuan, J | 1 |
| Chen, W | 1 |
| Carlsten, C | 1 |
| Kaufman, JD | 1 |
| Trenga, CA | 1 |
| Allen, J | 1 |
| Peretz, A | 1 |
| Sullivan, JH | 1 |
| Min, JY | 1 |
| Paek, D | 1 |
| Cho, SI | 1 |
| Min, KB | 1 |
| Cheng, S | 1 |
| Lyass, A | 1 |
| Massaro, JM | 1 |
| O'Connor, GT | 1 |
| Keaney, JF | 1 |
| Vasan, RS | 1 |
| Lancel, S | 1 |
| Montaigne, D | 1 |
| Marechal, X | 1 |
| Marciniak, C | 1 |
| Hassoun, SM | 1 |
| Decoster, B | 1 |
| Ballot, C | 1 |
| Blazejewski, C | 1 |
| Corseaux, D | 1 |
| Lescure, B | 1 |
| Motterlini, R | 1 |
| Neviere, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Association of Cigarette Smoking on Exercise Capacity and Skeletal Muscle Function in Taiwan Adult Smokers[NCT04688177] | 52 participants (Actual) | Observational | 2020-12-03 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carbon monoxide and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Thrombotic markers in metabolic syndrome subjects exposed to diesel exhaust.
Topics: Adult; Air Pollutants; Biomarkers; Carbon Monoxide; Cross-Over Studies; Female; Humans; Male; Metabo | 2008 |
5 other studies available for carbon monoxide and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Early changes in the components of the metabolic syndrome in a group of smokers after tobacco cessation.
Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Carbon Monoxide; Cholestero | 2014 |
Associations of Exhaled Carbon Monoxide and Fractional Exhaled Nitric Oxide with Metabolic Syndrome: A Cohort Study.
Topics: Adult; Aged; Breath Tests; Carbon Monoxide; China; Cross-Sectional Studies; Female; Humans; Male; Me | 2016 |
Exposure to environmental carbon monoxide may have a greater negative effect on cardiac autonomic function in people with metabolic syndrome.
Topics: Autonomic Nervous System; Carbon Monoxide; Environmental Exposure; Heart; Humans; Metabolic Syndrome | 2009 |
Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community.
Topics: Adult; Carbon Monoxide; Cardiovascular Diseases; Cross-Sectional Studies; Data Collection; Exhalatio | 2010 |
Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome.
Topics: Animals; Antimetabolites; Autophagy; Carbon Monoxide; Dietary Fats; Female; Heart Diseases; Humans; | 2012 |